1. Home
  2. MBAV vs CYRX Comparison

MBAV vs CYRX Comparison

Compare MBAV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBAV
  • CYRX
  • Stock Information
  • Founded
  • MBAV 2024
  • CYRX 1999
  • Country
  • MBAV United States
  • CYRX United States
  • Employees
  • MBAV N/A
  • CYRX N/A
  • Industry
  • MBAV
  • CYRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBAV
  • CYRX Health Care
  • Exchange
  • MBAV NYSE
  • CYRX Nasdaq
  • Market Cap
  • MBAV 368.4M
  • CYRX 310.4M
  • IPO Year
  • MBAV 2024
  • CYRX N/A
  • Fundamental
  • Price
  • MBAV $10.25
  • CYRX $6.09
  • Analyst Decision
  • MBAV
  • CYRX Strong Buy
  • Analyst Count
  • MBAV 0
  • CYRX 6
  • Target Price
  • MBAV N/A
  • CYRX $11.33
  • AVG Volume (30 Days)
  • MBAV 13.4K
  • CYRX 669.3K
  • Earning Date
  • MBAV 01-01-0001
  • CYRX 03-04-2025
  • Dividend Yield
  • MBAV N/A
  • CYRX N/A
  • EPS Growth
  • MBAV N/A
  • CYRX N/A
  • EPS
  • MBAV N/A
  • CYRX N/A
  • Revenue
  • MBAV N/A
  • CYRX $228,385,000.00
  • Revenue This Year
  • MBAV N/A
  • CYRX $9.31
  • Revenue Next Year
  • MBAV N/A
  • CYRX $8.36
  • P/E Ratio
  • MBAV N/A
  • CYRX N/A
  • Revenue Growth
  • MBAV N/A
  • CYRX N/A
  • 52 Week Low
  • MBAV $9.97
  • CYRX $4.58
  • 52 Week High
  • MBAV $10.53
  • CYRX $20.11
  • Technical
  • Relative Strength Index (RSI)
  • MBAV N/A
  • CYRX 47.97
  • Support Level
  • MBAV N/A
  • CYRX $6.02
  • Resistance Level
  • MBAV N/A
  • CYRX $6.60
  • Average True Range (ATR)
  • MBAV 0.00
  • CYRX 0.70
  • MACD
  • MBAV 0.00
  • CYRX 0.05
  • Stochastic Oscillator
  • MBAV 0.00
  • CYRX 56.05

About MBAV M3-BRIGADE ACQUISITION V CORP

M3-Brigade Acquisition V Corp is a blank check company.

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: